Product Information
HYDROCORT-PRAMOXINE 1%-1% CRM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.8892 per GM under NDC 45802014464. Its NADAC has been published 377 times since Jul 17, 2019.
FDA first approved this application before 1982.
Strength
1; 1 g/100g; g/100g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802014464
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085368FDA Approved
Before 1982
On Market Since
4/13/2010
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORT-PRAMOXINE 1%-1% CRM has been published 377 times since Jul 17, 2019, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8892 per GM |
|---|---|
| All-time high | $3.8226 (Feb 12, 2020) |
| All-time low | $2.8892 (Sep 23, 2026) |
| 52-week high | $3.4464 |
| 52-week low | $2.8892 |
| Median price | $3.4540 |
| Average price | $3.4609 |
| Largest weekly change | +17.7% (Jan 18, 2023) |
| Weeks tracked | 377 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocortisone acetate pramoxine hcl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocortisone acetate pramoxine hcl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORT-PRAMOXINE 1%-1% CRM?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORT-PRAMOXINE 1%-1% CRM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.8892 per GM (NDC 45802014464), effective Sep 30, 2026.
How has the price of HYDROCORT-PRAMOXINE 1%-1% CRM changed over time?
Over the history we have for it, the NADAC for HYDROCORT-PRAMOXINE 1%-1% CRM has declined 21.3%. It has been tracked across 377 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCORT-PRAMOXINE 1%-1% CRM?
Since Jul 17, 2019, the NADAC for HYDROCORT-PRAMOXINE 1%-1% CRM has ranged from a low of $2.8892 (Sep 23, 2026) to a high of $3.8226 (Feb 12, 2020), with a median of $3.4540 per GM.
Are there cheaper alternatives to HYDROCORT-PRAMOXINE 1%-1% CRM?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCORT-PRAMOXINE 1%-1% CRM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCORT-PRAMOXINE 1%-1% CRM?
HYDROCORT-PRAMOXINE 1%-1% CRM (NDC 45802014464) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.